Literature DB >> 11034257

Limited sampling model for the estimation of pharmacokinetic parameters in children.

I Mahmood1.   

Abstract

A limited sampling model (LSM) is proposed for the first-time assessment of pharmacokinetic parameters (area under the concentration-time curve (AUC), Cmax, and T1/2) in children after a single oral dose of drug. Three drugs were evaluated in this study. The LSM was developed for each drug from the data of 10 healthy adult volunteers. The relationship at selected time points between plasma concentration and the AUC or Cmax was evaluated by multiple linear regression. The multiple linear regression that gave the best correlation coefficient (r) for 3 sampling times versus AUC or Cmax was chosen as the LSM. Pharmacokinetic parameters generated using sparse sampling (3 blood samples) were compared with pharmacokinetic parameters generated using extensive sampling (>7 blood samples). The results indicated that a limited sampling model can be developed from adult data to estimate pharmacokinetic parameters in children with fair degree of accuracy.

Entities:  

Mesh:

Year:  2000        PMID: 11034257     DOI: 10.1097/00007691-200010000-00005

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  3 in total

1.  Evaluation of limited sampling models for prediction of oral midazolam AUC for CYP3A phenotyping and drug interaction studies.

Authors:  Silke C Mueller; Bernd Drewelow
Journal:  Eur J Clin Pharmacol       Date:  2012-11-07       Impact factor: 2.953

Review 2.  Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings.

Authors:  Iftekhar Mahmood
Journal:  Clin Pharmacokinet       Date:  2014-04       Impact factor: 6.447

Review 3.  A systematic review of limited sampling strategies for platinum agents used in cancer chemotherapy.

Authors:  Gabriel W Loh; Lillian S L Ting; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.